Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication
Open Access
- 27 October 2021
- journal article
- review article
- Published by Hindawi Limited in Oxidative Medicine and Cellular Longevity
- Vol. 2021, 1-20
- https://doi.org/10.1155/2021/2990326
Abstract
Nanomedicine and plasma medicine are innovative and multidisciplinary research fields aiming to employ nanotechnology and gas plasma to improve health-related treatments. Especially cancer treatment has been in the focus of both approaches because clinical response rates with traditional methods that remain improvable for many types of tumor entities. Here, we discuss the recent progress of nanotechnology and gas plasma independently as well as in the concomitant modality of nanoplasma as multimodal platforms with unique capabilities for addressing various therapeutic issues in oncological research. The main features, delivery vehicles, and nexus between reactivity and therapeutic outcomes of nanoparticles and the processes, efficacy, and mechanisms of gas plasma are examined. Especially that the unique feature of gas plasma technology, the local and temporally controlled deposition of a plethora of reactive oxygen, and nitrogen species released simultaneously might be a suitable additive treatment to the use of systemic nanotechnology therapy approaches. Finally, we focus on the convergence of plasma and nanotechnology to provide a suitable strategy that may lead to the required therapeutic outcomes.Funding Information
- Bundesministerium für Bildung und Forschung (03Z22DN11)
This publication has 250 references indexed in Scilit:
- Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric PlasmaPLOS ONE, 2013
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF NanomedicineClinical Cancer Research, 2010
- Polymer particle shape independently influences binding and internalization by macrophagesJournal of Controlled Release, 2010
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Effect of cholesterol on the structure of a phospholipid bilayerProceedings of the National Academy of Sciences of the United States of America, 2009
- Physical approaches to biomaterial designNature Materials, 2009
- Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted CarriersMolecular Therapy, 2008
- Phase I Trial of a Pathotropic Retroviral Vector Expressing a Cytocidal Cyclin G1 Construct (Rexin-G) in Patients With Advanced Pancreatic CancerMolecular Therapy, 2008
- A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulationBritish Journal of Cancer, 2007
- Shape effects of filaments versus spherical particles in flow and drug deliveryNature Nanotechnology, 2007